MannKind Corp
MNKD
#5812
Rank
C$1.76 B
Marketcap
C$5.50
Share price
3.72%
Change (1 day)
-27.70%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): C-$0.26

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is C-$0.18. In 2022 the company made an earnings per share (EPS) of C-$0.48 a decrease over its 2021 EPS that were of C-$0.45.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.26-46.13%
2022C-$0.486.25%
2021C-$0.4528%
2020C-$0.35-7.41%
2019C-$0.38-55.74%
2018C-$0.86-45.05%
2017C-$1.57-188.1%
2016C$1.78-128.31%
2015C-$6.2774.51%
2014C-$3.60-20.31%
2013C-$4.51-32.63%
2012C-$6.70-28.03%
2011C-$9.31-12%
2010C-$10.57-27.54%
2009C-$14.59-30.3%
2008C-$20.94-18.85%
2007C-$25.80-19.03%
2006C-$31.8656.94%
2005C-$20.30-21.74%
2004C-$25.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.07-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$5.75-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
C$43.52-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.40-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
C$4.96-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$4.17 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA